Table 1 Preoperative and demographics factors for patients with periampullary lesions undergoing pancreaticoduodenectomy.

From: Risk factors for delayed gastric emptying in pancreaticoduodenectomy

 

Total

DGE (+)

DGE (−)

p value

Patients, n (%)

600

46 (7.7%)

554 (92.3%)

 

Sex

   

0.289

 Female

283 (47.2%)

24 (8.5%)

259 (91.5%)

 

 Male

317 (52.8%)

22 (6.9%)

295 (93.1%)

 

Age, year old

   

0.583

 Median (range)

66 (19 – 97)

66 (43 – 89)

66 (19 – 97)

 

 Mean ± SD

65.1 ± 12.2

66.1 ± 10.5

65.1 ± 12.3

 

Nausea/vomiting

   

0.019

 Yes

127 (21.2%)

16 (12.6%)

111 (87.4%)

 

 No

473 (78.8%)

30 (6.3%)

443 (93.7%)

 

Diabetes mellitus

   

0.144

 Yes

162 (27.0%)

16 (9.9%)

146 (90.1%)

 

 No

438 (73.0%)

30 (6.8%)

408 (93.2%)

 

BMI

   

0.455

 Median (range)

23.2 (14.5–36.2)

22.7 (16.9–32.9)

23.3 (14.5–36.2)

 

 Mean ± SD

23.5 ± 3.5

23.1 ± 3.6

23.5 ± 3.5

 

ASA physical status classification

   

0.307

  < 2

417 (69.5%)

30 (7.2%)

387 (92.8%)

 

  > 3

183 (30.5%)

16 (8.7%)

167 (91.3%)

 

Jaundice

   

0.023

 Yes

314 (52.3%)

31 (9.9%)

283 (90.1%)

 

 No

286 (47.7%)

15 (5.2%)

271 (94.8%)

 

Body weight loss

   

0.303

 Yes

170 (28.3%)

15 (8.8%)

155 (91.2%)

 

 No

430 (71.7%)

31 (7.2%)

399 (92.8%)

 

Periampullary lesions

   

0.189

 Pancreatic head adenocarcinoma

234 (39.0%)

21 (9.0%)

213 (91.0%)

 

 Ampullary adenocarcinoma

129 (21.5%)

12 (9.3%)

117 (90.7%)

 

Distal CBD adenocarcinoma

36 (6.0%)

1 (2.8%)

35 (97.2%)

 

 Duodenal adenocarcinoma

28 (4.7%)

2 (7.1%)

26 (92.9%)

 

 Other malignancy

80 (13.3%)

8 (10.0%)

72 (90.0%)

 

 Other benign lesion

70 (11.7%)

0

70 (100%)

 

 Chronic pancreatitis

23 (3.8%)

2 (8.7%)

21 (91.3%)

 
  1. DGE delayed gastric emptying, SD standard deviation, BMI body mass index, ASA American Society of Anesthesiologists, CBD common bile duct.